Alectinib Products | Cleanchem - Alectinib is an ALK inhibitor used to treat ALK-positive non-small cell lung cancer (NSCLC). It blocks the abnormal ALK fusion proteins that drive tumor growth. Alectinib has shown effectiveness in both systemic and brain metastases. It is taken orally and is generally well-tolerated with manageable side effects.

Cat. No: CL-ACNB-NO-01

CAS No: NA

Mol. F: C30H33N5O3

Mol. Wt: 511.6

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-02

CAS No: NA

Mol. F: C30H33N5O4

Mol. Wt: 527.63

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-03

CAS No: NA

Mol. F: C30H34N4O5

Mol. Wt: 530.63

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-04

CAS No: NA

Mol. F: C30H33N5O4

Mol. Wt: 527.61

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-05

CAS No: NA

Mol. F: C30H35N5O4

Mol. Wt: 529.64

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-06

CAS No: NA

Mol. F: C34H43N5O4

Mol. Wt: 585.75

Inv. Status: Custom Synthesis

Cat. No: CL-ACNB-NO-07

CAS No: NA

Mol. F: C29H35N5O2

Mol. Wt: 485.63

Inv. Status: Custom Synthesis